- Friday 1st of October 2021
Can Malegra 120 be used after a heart attack?
Malegra 120 (which contains sildenafil) after a heart attack requires careful consideration and medical supervision. Here are key points to keep in mind: Consult Your Healthcare Provider: Before starting Malegra 120, discuss your medical history with your healthcare provider, especially your history of heart attack. They will evaluate your overall cardiovascular health and determine if it's safe for you. Assess Cardiac Health: Your doctor will assess whether your heart is sufficiently recovered and stable enough to handle the potential cardiovascular effects of sildenafil. Medication Interactions: Sildenafil can interact with medications used for heart conditions, particularly nitrates, which can lead to dangerous drops in blood pressure. Ensure your doctor is aware of all medications you are taking. Start with a Lower Dose: If approved to use Malegra 120 mg your doctor might suggest starting with a lower dose to monitor how you respond and to minimize any risks. Monitor for Side Effects: Be vigilant for any side effects, such as chest pain, dizziness, or shortness of breath, and report them to your healthcare provider immediately. Lifestyle Considerations: Managing your heart health through lifestyle changes (diet, exercise) can complement the use of erectile dysfunction medications and improve overall outcomes. Always prioritize your cardiovascular health and follow your doctor’s recommendations closely to ensure safe use of Malegra 120 after a heart attack.
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply